{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:10:51Z","timestamp":1779210651894,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Canine heartworm (\n                      <jats:italic>Dirofilaria immitis<\/jats:italic>\n                      ), a filarial parasite endemic in many countries worldwide, can cause life-threatening disease in dogs if left untreated. Two laboratory studies and one field study were conducted to evaluate the efficacy of Credelio Quattro, a novel chewable tablet containing moxidectin in combination with lotilaner, praziquantel and pyrantel, for the prevention of heartworm disease caused by\n                      <jats:italic>D. immitis<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In the laboratory studies, dogs were inoculated with 50\n                      <jats:italic>D. immitis<\/jats:italic>\n                      L3 larvae on Day \u2013 30. Eight dogs per group were randomized to receive either a placebo or Credelio Quattro at the minimum effective dosage of 0.02\u00a0mg\/kg moxidectin, 20\u00a0mg\/kg lotilaner, 5\u00a0mg\/kg praziquantel, and 5\u00a0mg\/kg pyrantel on Day 0. One of the studies also included a lotilaner-only treated group to demonstrate non-interference. Efficacy was evaluated\u2009~\u2009150\u00a0days post-inoculation utilizing adult heartworm counts collected at necropsy. The field study enrolled client-owned dogs,\u2009\u2265\u20098 eight weeks of age, weighing at least 1.5\u00a0kg, from 13 geographically diverse veterinary clinics throughout the USA. Dogs were randomized in a 1:1 ratio to receive either Credelio Quattro or a positive control product, Simparica Trio\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (moxidectin\/sarolaner\/pyrantel), at the recommended label dosages for 11 consecutive months. Efficacy was evaluated on Day 330 by assessing the detection of adult heartworm infections using antigen and microfilarial tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In both laboratory studies, no adult heartworms were collected from any of the dogs treated with a single dose of Credelio Quattro. In contrast, all dogs treated with placebo (range 13\u201340) or lotilaner-only (range 9\u201342) had adults present. A total of 372 dogs were enrolled in the field study (191 Credelio Quattro, 181 Simparica Trio). At the end of the study, no dogs from either treatment group tested positive for adult heartworms. Credelio Quattro was well tolerated in all studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The laboratory studies demonstrated Credelio Quattro as 100% effective for the prevention of heartworm disease caused by\n                      <jats:italic>D. immitis<\/jats:italic>\n                      in dogs. Additionally, no dogs in the field study tested positive for adult heartworm infection after 11 consecutive monthly doses of Credelio Quattro.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-026-07379-0","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:07:25Z","timestamp":1775473645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of a novel chewable tablet (Credelio Quattro\u2122) containing lotilaner, moxidectin, praziquantel, and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs"],"prefix":"10.1186","volume":"19","author":[{"given":"Lisa","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig R.","family":"Reinemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour","family":"Abdelmoneim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"7379_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.rvsc.2020.04.002","volume":"131","author":"D Anvari","year":"2020","unstructured":"Anvari D, Narouei E, Daryani A, Sarvi S, Moosazadeh M, Hezarjaribi HZ, et al. The global status of Dirofilaria immitis in dogs: a systematic review and meta-analysis based on published articles. Res Vet Sci. 2020;131:104\u201316. https:\/\/doi.org\/10.1016\/j.rvsc.2020.04.002.","journal-title":"Res Vet Sci"},{"key":"7379_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-7-206","volume":"7","author":"C Genchi","year":"2014","unstructured":"Genchi C, Bowman D, Drake J. Canine heartworm disease (Dirofilaria immitis) in Western Europe: survey of veterinary awareness and perceptions. Parasit Vectors. 2014;7:206. https:\/\/doi.org\/10.1186\/1756-3305-7-206.","journal-title":"Parasit Vectors"},{"key":"7379_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.vetpar.2005.04.006","volume":"133","author":"N Labarthe","year":"2005","unstructured":"Labarthe N, Guerrero J. Epidemiology of heartworm: what is happening in South America and Mexico? Vet Parasitol. 2005;133:149\u201356. https:\/\/doi.org\/10.1016\/j.vetpar.2005.04.006.","journal-title":"Vet Parasitol"},{"key":"7379_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-019-3633-2","volume":"12","author":"SW Self","year":"2019","unstructured":"Self SW, Pulaski CN, McMahan CS, Brown DA, Yabsley MJ, Gettings JR. Regional and local temporal trends in the prevalence of canine heartworm infection in the contiguous United States: 2012\u20132018. Parasit Vectors. 2019;12:380. https:\/\/doi.org\/10.1186\/s13071-019-3633-2.","journal-title":"Parasit Vectors"},{"key":"7379_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpddr.2021.03.004","volume":"16","author":"S Noack","year":"2021","unstructured":"Noack S, Harrington J, Carithers DS, Kaminsky R, Selzer PM. Heartworm disease\u2014overview, intervention, and industry perspective. Int J Parasitol Drugs Drug Resist. 2021;16:65\u201389. https:\/\/doi.org\/10.1016\/j.ijpddr.2021.03.004.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7379_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-016-1476-7","volume":"9","author":"BL Blagburn","year":"2016","unstructured":"Blagburn BL, Arther RG, Dillon AR, Butler JM, Bowles JV, von Simson C, et al. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis. Parasit Vectors. 2016;9:191. https:\/\/doi.org\/10.1186\/s13071-016-1476-7.","journal-title":"Parasit Vectors"},{"key":"7379_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-04760-z","volume":"14","author":"KL Riggs","year":"2021","unstructured":"Riggs KL, Wiseman S. Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio((R)) Plus) in juvenile and adult dogs. Parasit Vectors. 2021;14:285. https:\/\/doi.org\/10.1186\/s13071-021-04760-z.","journal-title":"Parasit Vectors"},{"key":"7379_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.ijpara.2021.08.006","volume":"51","author":"RK Prichard","year":"2021","unstructured":"Prichard RK. Macrocyclic lactone resistance in Dirofilaria immitis: risks for prevention of heartworm disease. Int J Parasitol. 2021;51:1121\u201332. https:\/\/doi.org\/10.1016\/j.ijpara.2021.08.006.","journal-title":"Int J Parasitol"},{"key":"7379_CR9","unstructured":"Current canine guidelines for the prevention, diagnosis, and management of heartworm (Dirofilaria immitis) infection in dogs announces updated guidelines on canine heartworm disease.: American Heartworm Society. 2018. Accessed 09 Apr 2024."},{"key":"7379_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2460\/javma.252.9.1084","volume":"252","author":"T Grant","year":"2018","unstructured":"Grant T, Wiseman S, Snyder DE. Effects of milbemycin oxime, combined with spinosad, when administered orally to microfilaremic dogs infected with adult heartworms (Dirofilaria immitis). J Am Vet Med Assoc. 2018;252:1084\u20139. https:\/\/doi.org\/10.2460\/javma.252.9.1084.","journal-title":"J Am Vet Med Assoc"},{"key":"7379_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s13071-019-3685-3","volume":"12","author":"TL McTier","year":"2019","unstructured":"McTier TL, Six RH, Pullins A, Chapin S, Kryda K, Mahabir SP, et al. Preventive of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Diroflaria immitis) strains in dogs. Parasit Vectors. 2019;12:444. https:\/\/doi.org\/10.1186\/s13071-019-3685-3.","journal-title":"Parasit Vectors"},{"key":"7379_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpddr.2019.06.002","volume":"10","author":"RK Prichard","year":"2019","unstructured":"Prichard RK, Geary TG. Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance. Int J Parasitol Drugs Drug Resist. 2019;10:69\u201383. https:\/\/doi.org\/10.1016\/j.ijpddr.2019.06.002.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7379_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-05104-7","volume":"15","author":"MD Savadelis","year":"2022","unstructured":"Savadelis MD, McTier TL, Kryda K, Maeder SJ, Woods DJ. Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance. Parasit Vectors. 2022;15:82. https:\/\/doi.org\/10.1186\/s13071-021-05104-7.","journal-title":"Parasit Vectors"},{"key":"7379_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001883","volume":"6","author":"C Menez","year":"2012","unstructured":"Menez C, Sutra JF, Prichard R, Lespine A. Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (\u2212\/\u2212) mice and effects on mammalian GABA(A) channel activity. PLoS Negl Trop Dis. 2012;6:e1883. https:\/\/doi.org\/10.1371\/journal.pntd.0001883.","journal-title":"PLoS Negl Trop Dis"},{"key":"7379_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-2431-y","volume":"10","author":"DD Bowman","year":"2017","unstructured":"Bowman DD, McTier TL, Adams EL, Mahabir SP, Login JA, Bidgood T, et al. Evaluation of the efficacy of ProHeart\u00ae 6 (moxidectin) against a resistant isolate of Dirofilaria immitis (JYD-34) in dogs. Parasit Vectors. 2017;10:502. https:\/\/doi.org\/10.1186\/s13071-017-2431-y.","journal-title":"Parasit Vectors"},{"key":"7379_CR16","unstructured":"Companion Animal Parasite Council: General guidelines for Dogs and Cats. https:\/\/capcvet.org\/guidelines\/general-guidelines\/. 2025. Accessed 14 Aug 2025."},{"key":"7379_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-3164.2009.00838.x","volume":"20","author":"MW Dryden","year":"2009","unstructured":"Dryden MW. Flea and tick control in the 21st century: challenges and opportunities. Vet Dermatol. 2009;20:435\u201340. https:\/\/doi.org\/10.1111\/j.1365-3164.2009.00838.x.","journal-title":"Vet Dermatol"},{"key":"7379_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bbrc.2009.11.131","volume":"391","author":"Y Ozoe","year":"2010","unstructured":"Ozoe Y, Asahi M, Ozoe F, Nakahira K, Mita T. The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels. Biochem Biophys Res Commun. 2010;391:744\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.131.","journal-title":"Biochem Biophys Res Commun"},{"key":"7379_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-2476-y","volume":"10","author":"M Murphy","year":"2017","unstructured":"Murphy M, Garcia R, Karadzovska D, Cavalleri D, Snyder D, Seewald W, et al. Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio) against four common species of ticks affecting dogs in North America. Parasit Vectors. 2017;10:523. https:\/\/doi.org\/10.1186\/s13071-017-2476-y.","journal-title":"Parasit Vectors"},{"key":"7379_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-019-3873-1","volume":"13","author":"L Young","year":"2020","unstructured":"Young L, Karadzovska D, Wiseman S, Helbig R. Efficacy of lotilaner (Credelio) against the adult cat flea, Ctenocephalides felis and flea eggs following oral administration to dogs. Parasit Vectors. 2020;13:25. https:\/\/doi.org\/10.1186\/s13071-019-3873-1.","journal-title":"Parasit Vectors"},{"key":"7379_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-018-2970-x","volume":"11","author":"I Wright","year":"2018","unstructured":"Wright I. Lotilaner - a novel formulation for cats provides systemic tick and flea control. Parasit Vectors. 2018;11:407. https:\/\/doi.org\/10.1186\/s13071-018-2970-x.","journal-title":"Parasit Vectors"},{"key":"7379_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/2121273b0","volume":"212","author":"WC Austin","year":"1966","unstructured":"Austin WC, Courtney W, Danilewicz JC, Morgan DH, Conover LH, Howes HL Jr., et al. Pyrantel tartrate, a new anthelmintic effective against infections of domestic animals. Nature. 1966;212:1273\u20134. https:\/\/doi.org\/10.1038\/2121273b0.","journal-title":"Nature"},{"key":"7379_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tvjl.2007.06.021","volume":"178","author":"SR Kopp","year":"2008","unstructured":"Kopp SR, Kotze AC, McCarthy JS, Traub RJ, Coleman GT. Pyrantel in small animal medicine: 30 years on. Vet J. 2008;178:177\u201384. https:\/\/doi.org\/10.1016\/j.tvjl.2007.06.021.","journal-title":"Vet J"},{"key":"7379_CR24","first-page":"767","volume":"65","author":"RE Bradley","year":"1970","unstructured":"Bradley RE, Conway DP. Evaluation of pyrantel hydrochloride as an anthelmintic in dogs. Vet Med Small Anim Clin. 1970;65:767\u20139.","journal-title":"Vet Med Small Anim Clin"},{"key":"7379_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/med.2610030204","volume":"3","author":"P Andrews","year":"1983","unstructured":"Andrews P, Thomas H, Pohlke R, Seubert J. Praziquantel. Med Res Rev. 1983;3:147\u2013200. https:\/\/doi.org\/10.1002\/med.2610030204.","journal-title":"Med Res Rev"},{"key":"7379_CR26","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/BF01945954","volume":"33","author":"J Seubert","year":"1977","unstructured":"Seubert J, Pohlke R, Loebich F. Synthesis and properties of Praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes. Experientia. 1977;33:1036\u20137. https:\/\/doi.org\/10.1007\/BF01945954.","journal-title":"Experientia"},{"key":"7379_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0034-5288(18)33092-3","volume":"24","author":"H Thomas","year":"1978","unstructured":"Thomas H, Gonnert R. The efficacy of praziquantel against cestodes in cats, dogs and sheep. Res Vet Sci. 1978;24:20\u20135.","journal-title":"Res Vet Sci"},{"key":"7379_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-025-06757-4","volume":"18","author":"S Charles","year":"2025","unstructured":"Charles S, Deuster K, Wang X, Wiseman S, Reinemeyer CR, van der Mescht L, et al. Efficacy of a novel chewable tablet (Credelio Quattro\u2122) containing Lotilaner, Moxidectin, Praziquantel, and Pyrantel for the treatment and control of hookworm infections in dogs. Parasit Vectors. 2025;18:125. https:\/\/doi.org\/10.1186\/s13071-025-06757-4.","journal-title":"Parasit Vectors"},{"key":"7379_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-025-06932-7","volume":"18","author":"S Charles","year":"2025","unstructured":"Charles S, Wiseman S, Savadelis MD, Nichols E, Young L. Field efficacy and safety evaluation of a novel chewable tablet (Credelio Quattro\u2122) containing Lotilaner, Moxidectin, Praziquantel, and Pyrantel against gastrointestinal nematode infections in dogs in the USA. Parasit Vectors. 2025;18:297. https:\/\/doi.org\/10.1186\/s13071-025-06932-7.","journal-title":"Parasit Vectors"},{"key":"7379_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-025-06968-9","volume":"18","author":"S Charles","year":"2025","unstructured":"Charles S, Wiseman S, Wang X, et al. Efficacy of a novel chewable tablet (Credelio Quattro\u2122) containing Lotilaner, Moxidectin, Praziquantel, and Pyrantel against Toxocara canis and Toxascaris leonina infections in dogs. Parasit Vectors. 2025;18:297. https:\/\/doi.org\/10.1186\/s13071-025-06968-9.","journal-title":"Parasit Vectors"},{"key":"7379_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-025-06735-w","volume":"18","author":"S Charles","year":"2025","unstructured":"Charles S, Altreuther A, Wang X, Wiseman S, Reinemeyer CR, Snyder DE, et al. Efficacy of a novel chewable tablet (Credelio Quattro\u2122) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs. Parasit Vectors. 2025;18:99. https:\/\/doi.org\/10.1186\/s13071-025-06735-w.","journal-title":"Parasit Vectors"},{"key":"7379_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0304-4017(01)00615-x","volume":"103","author":"J Vercruysse","year":"2002","unstructured":"Vercruysse J, Holdsworth P, Letonja T, Conder G, Hamamoto K, Okano K, et al. International harmonisation of anthelmintic efficacy guidelines (Part 2). Vet Parasitol. 2002;103:277\u201397. https:\/\/doi.org\/10.1016\/s0304-4017(01)00615-x.","journal-title":"Vet Parasitol"},{"key":"7379_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-024-06603-z","volume":"17","author":"J Prullage","year":"2024","unstructured":"Prullage J, Frost J, DiCosty U, Martin E, Dumont P, Yoon S, et al. Preventive efficacy of six monthly doses of NexGard\u00ae PLUS or Simparica Trio\u00ae against a macrocyclic lactone-resistant isolate (JYD-34) of Dirofilaria immitis and of a single dose of NexGard PLUS against a susceptible isolate. Parasit Vectors. 2024;17:519. https:\/\/doi.org\/10.1186\/s13071-024-06603-z.","journal-title":"Parasit Vectors"},{"key":"7379_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-022-05571-6","volume":"304","author":"E Curry","year":"2022","unstructured":"Curry E, Prichard R. Development of rapid in vitro colorimetric enzymatic activity assay to differentiate macrocyclic lactone susceptible and resistant Dirofilaria immitis isolates. Vet Parasitol. 2022;304:109696. https:\/\/doi.org\/10.1186\/s13071-022-05571-6.","journal-title":"Vet Parasitol"},{"key":"7379_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijpddr.2023.07.002","volume":"23","author":"S Kumar","year":"2023","unstructured":"Kumar S, Prichard RK, Long T. Droplet digital PCR as a tool to detect resistant isolates of Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2023;23:10\u20138. https:\/\/doi.org\/10.1016\/j.ijpddr.2023.07.002.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7379_CR36","unstructured":"Companion Animal Parasite Council Parasite Prevalence Maps, Companion Animal Parasite Council | Parasite Prevalence Maps. 2025. Accessed 07 Nov 2025."},{"key":"7379_CR37","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cvsm.2009.06.003","volume":"39","author":"DD Bowman","year":"2009","unstructured":"Bowman DD, Atkins CE. Heartworm biology, treatment, and control. Vet Clin North Am Small Anim Pract. 2009;39:1127\u201358. https:\/\/doi.org\/10.1016\/j.cvsm.2009.06.003.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"7379_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2025.100604","volume":"29","author":"E Curry","year":"2025","unstructured":"Curry E, Tack D, Rodriguez J, Brehm-Lowe D, Letherer J, Lineberry M, et al. Surveillance of single nucleotide polymorphisms correlated to macrocyclic lactone resistance in Dirofilaria immitis from client-owned dogs across the United States. Int J Parasitol Drugs Drug Resist. 2025;29:100604.\u00a0https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100604.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7379_CR39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.vetpar.2011.04.012","volume":"181","author":"C Bourguinat","year":"2011","unstructured":"Bourguinat C, Keller K, Bhan A, Peregrine A, Geary T, Prichard R. Macrocyclic lactone resistance in Dirofilaria immitis. Vet Parasitol. 2011;181:388\u201392. https:\/\/doi.org\/10.1016\/j.vetpar.2011.04.012.","journal-title":"Vet Parasitol"},{"key":"7379_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-014-0494-6","volume":"7","author":"CN Pulaski","year":"2014","unstructured":"Pulaski CN, Malone JB, Bourguinat C, Prichard R, Geary T, Ward D, et al. Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs. Parasit Vectors. 2014;7:494. https:\/\/doi.org\/10.1186\/s13071-014-0494-6.","journal-title":"Parasit Vectors"},{"key":"7379_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.vetpar.2015.04.002","volume":"210","author":"C Bourguinat","year":"2015","unstructured":"Bourguinat C, Lee AC, Lizundia R, Blagburn BL, Liotta JL, Kraus MS, et al. Macrocyclic lactone resistance in Dirofilaria immitis: failure of heartworm preventives and investigation of genetic markers for resistance. Vet Parasitol. 2015;210:167\u201378. https:\/\/doi.org\/10.1016\/j.vetpar.2015.04.002.","journal-title":"Vet Parasitol"},{"key":"7379_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-2436-6","volume":"10","author":"MJ Maclean","year":"2017","unstructured":"Maclean MJ, Savadelis MD, Coates R, Dzimianski MT, Jones C, Benbow C, et al. Does evaluation of in vitro microfilarial motility reflect the resistance status of Dirofilaria immitis isolates to macrocyclic lactones? Parasit Vectors. 2017;10:480. https:\/\/doi.org\/10.1186\/s13071-017-2436-6.","journal-title":"Parasit Vectors"},{"key":"7379_CR43","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ijpddr.2018.06.006","volume":"8","author":"C Ballesteros","year":"2018","unstructured":"Ballesteros C, Pulaski CN, Bourguinat C, Keller K, Prichard RK, Geary TG. Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2018;8:596\u2013606. https:\/\/doi.org\/10.1016\/j.ijpddr.2018.06.006.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7379_CR44","unstructured":"European Scientific Counsel Companion Animal Parasites (ESCCAP). Guidelines | ESCCAP. Guidelines | ESCCAP. Accessed 23 July 2025."},{"key":"7379_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-023-05690-8","volume":"16","author":"F Dantas-Torres","year":"2023","unstructured":"Dantas-Torres F, Ketzis J, P\u00e9rez Tort G, Mihalca AD, Baneth G, Otranto D, et al. Heartworm adulticide treatment: a tropical perspective. Parasit Vectors. 2023;16:148. https:\/\/doi.org\/10.1186\/s13071-023-05690-8.","journal-title":"Parasit Vectors"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-026-07379-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07379-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07379-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:52:11Z","timestamp":1779209531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-026-07379-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7379"],"URL":"https:\/\/doi.org\/10.1186\/s13071-026-07379-0","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols were reviewed and approved by the Animal Care and Use Committee of the institution performing the studies (21-04, 21-0269) and by the Elanco Animal Health Animal Care and Use Committee prior to study conduct (1651). The clinical field study was reviewed by the Elanco Animal Health Care and Use Committee (1650), and owner informed consent was obtained prior to patient enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LY and SW are employees of Elanco Animal Health.  CRR and MA were contracted to conduct the studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}